415 drug entries: the why, not only the how much

Principles of Cardiovascular Regulation and Receptive Dynamics Fundamentals of Hemodynamics

Enalapril and Ramipril ACE inhibitors (ACE inhibitors)

Losartan and Valsartan Angiotensin II Receptor Antagonists (ARA-II)

Sacubitril / Valsartan Neprilysin and Angiotensin Receptor Inhibitors (ARNI)

Spironolactone and Eplerenone Mineralocorticoid Receptor Antagonists (MRA)

Carvedilol and Metoprolol Succinate Adrenergic Blockers / Beta-Blockers

Amlodipine and Nifedipine Dihydropyridine calcium antagonists

Verapamil and Diltiazem Non-dihydropyridine calcium antagonists

Furosemide High Potency Loop Diuretics

Hydrochlorothiazide and Chlorthalidone Thiazidic and Thiazide Profile Diuretics

Empagliflozin and Dapagliflozin SGLT2 Inhibitors with Cardiac Benefit

Acetylsalicylic Acid (Aspirin) Antiplatelet Agents / COX-1 Inhibitors

Clopidogrel and Ticagrelor Platelet Antiplatelet Agents / P2Y12 Inhibitors

Rivaroxaban and Apixaban Direct Oral Anticoagulants (DOACs)

Heparin Sodium and Enoxaparin Parenteral Anticoagulants / Heparins

Amiodarone Class III Antiarrhythmics with Multichannel Action

Digoxin Cardiac Glycosides / Positive Inotropics

Nitroglycerin and Sodium Nitroprusside Direct Vasodilators and Nitrates

Integrated Summary of Clinical Adjustment and Safety Quick Reference Vademecum

Bases of respiratory pharmacology Physiological and Cellular Fundamentals

Salbutamol and Terbutaline Short-Acting $\beta_2$-Adrenergic Agonists (SABA)

Salmeterol, Formoterol, Indacaterol, Olodaterol and Vilanterol $\beta_2$-Adrenergic Agonists with Prolonged and Ultra-Prolonged Action

Ipratropium bromide Short Acting Muscarinic Antagonists (SAMA)

Tiotropium Bromide, Glycopyrronium, Aclidinium and Umeclidinium Long-Acting Muscarinic Antagonists (LAMA)

Fluticasone, Budesonide, Beclomethasone and Ciclesonide Inhaled Glucocorticoids (ICS)

Prednisone, Methylprednisolone, Hydrocortisone and Dexamethasone Systemic Glucocorticoids in Pulmonology

ICS/LABA, LAMA/LABA and Triple Therapy Associations (LAMA/LABA/ICS) Combination Therapies in a Single Device

Theophylline and Aminophylline Methylxanthines

Montelukast, Zafirlukast and Zileutón Leukotriene Receptor Antagonists (LTRA)

Disodium Cromoglycate and Sodium Nedocromil Chromones and Mast Cell Stabilizers

Omalizumab (Anti-IgE) Directed Biological Therapies (Part I)

Biologicals Anti-IL5 (Mepolizumab, Reslizumab), Anti-IL5R$\alpha$ (Benralizumab) and Anti-IL4R$\alpha$ (Dupilumab) Directed Biological Therapies (Part II)

Tezepelumab (Anti-TSLP) Third Generation Biologicals (Alarminas)

N-Acetylcysteine, Erdocysteine, Dornase Alfa and Poractant Alfa Mucolytics, Expectorants and Pulmonary Surfactants

Codeine, Dextromethorphan, Cloperastine and Levodropropizine Antitussive Drugs

Sildenafil, Bosentan, Ambrisentan, Epoprostenol and Riociguat Drugs for Pulmonary Arterial Hypertension (PAH)

Nintedanib and Pirfenidone Antifibrotic Drugs in DILD

Integration and Clinical Practice Integrated Analysis, Clinical Cases and Adjustment Algorithms

Adrenaline (Epinephrine) Adrenergic Agonists (Sympathomimetics)

Norepinephrine (Norepinephrine) Adrenergic Agonists (Sympathomimetics)

Dopamine Adrenergic Agonists (Sympathomimetics)

Dobutamine Adrenergic Agonists (Sympathomimetics)

Phenylephrine Adrenergic Agonists (Sympathomimetics)

Clonidine Adrenergic Agonists (Sympathomimetics)

Salbutamol (Albuterol) Adrenergic Agonists (Sympathomimetics)

Propranolol Adrenergic Antagonists (Sympaticolytics)

Metoprolol Adrenergic Antagonists (Sympaticolytics)

Carvedilol Adrenergic Antagonists (Sympaticolytics)

Labetalol Adrenergic Antagonists (Sympaticolytics)

Tamsulosin Adrenergic Antagonists (Sympaticolytics)

Phenoxybenzamine Adrenergic Antagonists (Sympaticolytics)

Bethanechol Cholinergic Agonists (Parasympathomimetics)

Pilocarpine Cholinergic Agonists (Parasympathomimetics)

Neostigmine and Pyridostigmine Cholinergic Agonists (Parasympathomimetics)

Donepezil Cholinergic Agonists (Parasympathomimetics)

Atropine Cholinergic Antagonists (Parasympatholytics)

Scopolamine (Hyoscine) Cholinergic Antagonists (Parasympatholytics)

Ipratropium and Tiotropium Bromide Cholinergic Antagonists (Parasympatholytics)

Oxybutynin Cholinergic Antagonists (Parasympatholytics)

Succinylcholine (Suxamethonium) Nicotinic Binding and Neuromuscular Plaque Modulators

Principles of Clinical Neuropharmacology Theoretical bases

Fluoxetine Selective Serotonin Reuptake Inhibitor (SSRI)

Venlafaxine Serotonin and Norepinephrine Reuptake Inhibitor (SNRI)

Amitriptyline Tricyclic Antidepressant (TCA)

Mirtazapine Noradrenergic and Specific Serotonergic Antidepressant (NaSSA)

Selegiline Monoamine oxidase inhibitor (MAOI)

Haloperidol Typical First Generation Antipsychotic (FGA)

Clozapine Second Generation Atypical Antipsychotic (SGA)

Risperidone Second Generation Atypical Antipsychotic (SGA)

Aripiprazole Third Generation Atypical Antipsychotic (Partial Agonist)

Lithium Carbonate Mood Stabilizer / Monovalent Cation

Valproic Acid (Sodium Valproate) Broad Spectrum Stabilizer and Antiepileptic

Lamotrigine Sodium and Glutamatergic Channel Stabilizer

Diazepam Anxiolytic / Long Half-Life Benzodiazepine

Zolpidem Non-Benzodiazepine Hypnotic / Compound Z

Methylphenidate CNS Stimulant / Dopamine and Norepinephrine Reuptake Inhibitor

Donepezil Acetylcholinesterase Inhibitor (IChE)

Synthesis and Comparative Tables Comparative analysis

Physiopathological Bases and Dynamic Mechanisms of Action Biophysical Fundamentals

Phenytoin Classic Sodium Channel Blocker / Antiepileptic

Carbamazepine Sodium Channel Blocker / Iminostilbene

Oxcarbazepine Keto-derived Analogue of Carbamazepine / Sodium Blocker

Ethosuximide T-type Calcium Channel Blocker / Succinimide

Phenobarbital GABA_A Allosteric Modulator / Barbiturate

Gabapentin Calcium Channel Modulator / alfa2delta Ligand

Pregabalin Calcium Channel Modulator / alfa2delta Ligand

Vigabatrin Irreversible GABA Transaminase Inhibitor / GABA Modulator

Topiramate Sodium Channel and Chlorine/Sulfamate Channel Modulator

Levetiracetam SV2A Vesicular Protein Ligand / Pyrrolidone

Brivaracetam High Affinity Analogue for SV2A Protein / Pyrrolidone

Lacosamide Slow Inactivation Modulator of Sodium Channels

Zonisamide Sodium and Calcium Blocker type T / Sulfonamide

Perampanel Non-Competitive AMPA Receptor Antagonist

Levodopa / Carbidopa (and Benserazide) Dopaminergic Precursor and DDC Inhibitor / Classic Antiparkinsonian

Pramipexole Non-Ergotic Dopamine Agonist / Selective D3 Receptor

Ropinirole Non-Ergotic Dopamine Agonist / D2 Modulator

Rotigotine Transdermal Non-Ergotic Dopamine Agonist / Continuous Modulator

Entacapone / Tolcapone Catechol-O-Methyltransferase (COMT) inhibitor

Rasagiline Selective and Irreversible MAO-B Inhibitor

Safinamide Reversible MAO-B Inhibitor and Channel Blocker / Double Mechanism

Biperiden Centrally Acting Muscarinic Antagonist / Anticholinergic

Amantadine NMDA Antagonist and Dopaminergic Facilitator / Antiviral

Synthesis and Comparative Tables of Advanced Pharmacotherapy Comparative analysis

Bases of anesthetic pharmacology Biophysical Mechanisms and Neurophysiology

Sevoflurane, Desflurane and Isoflurane Halogenated Inhalation Anesthetics

Nitrous Oxide and Xenon Non-Halogenated Inhalation Anesthetics

Sodium Thiopental Intravenous Anesthetics Barbiturates

Propofol Fast-Acting Hypnotics

Etomidate Intravenous Anesthetics Stabilizers

Ketamine Dissociative Anesthetics

Dexmedetomidine and Clonidine Selective Alpha-2 Adrenergic Agonists

Fentanyl, Sufentanil and Remifentanil Synthetic Opioid Analgesics

Succinylcholine (Suxamethonium) Depolarizing Neuromuscular Blockers

Cisatracurium, Rocuronium and Vecuronium Non-Depolarizing Neuromuscular Blockers

Sugammadex and Neostigmine Neuromuscular Blockade Reversal Agents

Procaine, Tetracaine and Benzocaine Ester Type Local Anesthetics

Lidocaine, Bupivacaine and Ropivacaine Amide Type Local Anesthetics

Ephedrine, Phenylephrine and Atropine Perioperative Hemodynamic Support

Dexamethasone, Ondansetron and Droperidol Prophylaxis and Treatment of PONV

Non-Opioid Strategies and Multimodal Blockade Opioid-Free Anesthesia (OFA)

Management Algorithms and Acute Crises Critically Relevant Perioperative Emergencies

Comparative Table of the Anesthetic Vademecum Synthesis Analysis and Quick Adjustment Guidelines

Physiopathological Bases of Pain and Inflammation Basics

Paracetamol (Acetaminophen) Non-Opioid Analgesic and Antipyretic

Metamizole (Dipyrone) Analgesic, Antipyretic and Spasmolytic

Ibuprofen Non-Selective Non-Steroidal Anti-Inflammatory Drug (NSAID)

Ketorolac Potent Short-Term Analgesic

Celecoxib Highly Selective COX-2 NSAID (Coxib)

Morphine Potent Major Opioid Analgesic (Narcotic)

Tramadol Dual Mechanism Opioid Analgesic (Weak Opioid)

Fentanyl Potent Synthetic Major Opioid Analgesic (Narcotic)

Sumatriptan Acute Antimigraine

Methotrexate csDMARD Reference in Rheumatology

Leflunomide csDMARD Immunomodulator

Adalimumab Biological Disease Modifying Drug (bDMARD)

Tofacitinib Synthetic Targeted Disease Modifying Drug (tsDMARD)

Colchicine Direct Cellular Action Antigotous

Allopurinol Hypouricemic Enzymatic Action

Synthesis: Atlas of Pharmacoselection and Toxicology Quick Guide to Clinical Selection

Principles of Hormonal Regulation and Therapeutic Adjustment Pharmacoclinical Fundamentals

Metformin Biguanids

Empagliflozin (and Dapagliflozin) SGLT2 inhibitors

Liraglutide / Semaglutide Incretin Analogues / GLP-1 Receptor Agonists

Sitagliptin DPP-4 inhibitors / Gliptins

Glimepiride Sulfonylureas

Pioglitazone Thiazolidinediones / Insulin Sensitizers

Insulin Glargine and Insulin Lispro Analog Insulins / Biological Therapy

Levothyroxine Sodium (T4) Thyroid Hormones

Methimazole (Thiamazole) and Propyl hysteractyl (PTU) Synthetic Antithyroids / Thionamides

Dexamethasone and Hydrocortisone Systemic Glucocorticoids

Fludrocortisone Acetate Synthetic Mineralocorticoids

Cabergoline and Octreotide Pituitary Modulators

Desmopressin (DDAVP) Vasopressin Analogues / Antidiuretic Hormones

Alendronate Sodium and Zoledronic Acid Bone Metabolism Modulators / Bisphosphonates

Denosumab and Teriparatide Biological Therapy and Bone Anabolics

Cinacalcet Hydrochloride Calcium Receptor Modulators / Calcimimetics

Atorvastatin (and Evolocumab) Hypolipidemics and Cholesterol Regulators

Integrated Fit and Safety Summary Comparative Table of Clinical Settings

Dynamics of transporters in the nephron Applied Renal Physiology

Acetazolamide Carbonic Anhydrase Inhibitor

Furosemide High Potency Loop Diuretic

Bumetanide High Potency Loop Diuretic

Torasemide Antialdosteronic Loop Diuretic

Ethacrynic Acid Non-Sulfonamide Loop Diuretic

Hydrochlorothiazide (HCTZ) Classic Thiazide Diuretic

Chlorthalidone Long-Action Thiazide-Like Diuretic

Indapamide Thiazide-Like Diuretic Vasodilator

Metolazone Potent Thiazide-Like Diuretic

Spironolactone Mineralocorticoid Receptor Antagonist

Eplerenone Selective Mineralocorticoid Receptor Antagonist

Finerenone Selective Nonsteroidal Antagonist of the Mineralocorticoid Receptor

Amiloride Epithelial Sodium Channel Blocker

Mannitol Osmotic Diuretic

Empagliflozin SGLT2 Inhibitor (Metabolic-Renal Diuretic)

Hopperptan Selective Vasopressin V2 Receptor Antagonist

Cross-drug interactions of diuretics Advanced Clinical Synthesis

Physiological Principles of Liquid Compartments Membrane Biophysics

Physiology of Volume Regulation and Osmolarity Hydrosaline Homeostasis

Isotonic Crystalloid Solutions Crystalloid Therapeutics

Hypotonic and Hypertonic Crystalloids Special Solutions

Colloid Solutions (Natural and Synthetic) Volume Expanders

Sodium Disorders I: Hyponatremia Sodium Disorders

Sodium II Disorders: Hypernatremia Sodium Homeostasis

Potassium Disorders I: Hypokalemia Potassium Homeostasis

Potassium II Disorders: Hyperkalemia Electrolytic Emergencies

Calcium Disorders Cation Homeostasis

Magnesium Disorders Cation Homeostasis

Phosphorus Disorders and Refeeding Syndrome Integration Anion Metabolism

Acid-Base Balance I: Classic Approach (Henderson-Hasselbalch) Physiology of Acid-Base Balance

Acid-Base Balance II: Physicochemical Approach (Stewart) Contemporary Physiological Theory

Metabolic Acidosis Clinical Entities

Metabolic Alkalosis Clinical Entities

Respiratory Disorders and Mixed Acid-Base Balance Disorders Analysis of Arterial Gases

Practical Prescription and Monitoring in Critical Patients Evidence-Based Fluid Therapy

Integrated Summary of Solutions and Safe Infusion Comparative Table of Clinical Settings

Bases of gastrointestinal pharmacology Physiological Fundamentals

Omeprazole (and derivatives: Esomeprazole, Pantoprazole) Proton Pump Inhibitors (PPI)

Famotidine Histamine H2 Receptor Antagonists

Sucralfate Mucosal Protectors and Cytoprotectors

Misoprostol Synthetic Prostaglandin Analogues

Aluminum Hydroxide, Magnesium Hydroxide and Calcium Carbonate Non-Systemic Chemical Antacids

Metoclopramide Prokinetics Dopaminergic Modulators

Domperidone and Cinitapride Peripheral and Selective Prokinetics

Prucalopride and Linaclotide New Generation Prokinetics and Secretagogues

Butylscopolamine and Trimebutine Hydroxide Antispasmodics and Spasmolytics

Ondansetron Antiemetics 5-HT3 Receptor Antagonists

Aprepitant (and Fosaprepitant) Antagonists of Neurokinin NK1 Receptors

Lactulose, Macrogol (PEG) and Bisacodyl Osmotic Laxatives and Irritants

Loperamide and Racecadotril Luminal and Systemic Antidiarrheals

Mesalazine and Sulfasalazine Anti-inflammatories Aminosalicytes (5-ASA)

Azathioprine Immunomodulators Immunosuppressants

Infliximab and Vedolizumab Directed Biological Therapies

Ursodeoxycholic Acid (UDCA), Pancreatin and Rifaximin Hepatobiliary, Pancreatic Drugs and Luminal Antibiotics

Synthesis and clinical application pearls Analysis of Clinical Cases and Adjustment Algorithms

Introduction and Analysis Methodology Clinical Context

Unfractionated Heparin (UFH) Parenteral Anticoagulants

Enoxaparin Sodium (LMWH) Parenteral Anticoagulants

Fondaparinux Sodium Parenteral Anticoagulants

Warfarin Sodium / Acenocoumarol Oral Anticoagulants

Rivaroxaban / Apixaban Direct Acting Oral Anticoagulants (DOACs)

Dabigatran Etexilate Direct Acting Oral Anticoagulants (DOACs)

Acetylsalicylic acid (AAS) Antiplatelet Agents

Clopidogrel Antiplatelet Agents

Ticagrelor / Prasugrel Antiplatelet Agents

Glycoprotein IIb/IIIa Inhibitors (Abciximab / Tirofiban) Antiplatelet Agents

Alteplase (rt-PA) / Tenecteplase Fibrinolytics

Tranexamic Acid Antifibrinolytics

Erythropoietic Agents (Epoetin Alfa / Darbepoetin) Hematopoietic Growth Factors

Colony Stimulating Factors (Filgrastim / Pegfilgrastim) Hematopoietic Growth Factors

Thrombopoietin analogues (Romiplostim / Eltrombopag) Hematopoietic Growth Factors

Factor Replacement Therapies (Factor VIII / Factor IX) Coagulation Factors

Emicizumab Immunotherapy in Hemostasis

Idarucizumab / Andexanet Alfa Antidotes and Reversers

Deferasirox / Deferoxamine Iron Chelators

Synthesis and Summary of Hematological Monitoring Integration and Advanced Review

Physiopathological Bases and Resistance Mechanisms Basics

Benzylpenicillins and Isoxazolylpenicillins Cell Wall Inhibitors

Aminopenicillins and Beta-lactamase Inhibitors Broad Spectrum and Synergistic Combinations

First and Second Generation Cephalosporins Bounded Spectrum Wall Inhibitors

Third and Fourth Generation Cephalosporins Broad Spectrum with CSF Penetration

Fifth Generation Cephalosporins and Siderophores Advanced Therapies and Extreme Resistance

Carbapenems Ultra-Broad Spectrum Wall Inhibitors

Monobactamics (Aztreonam) Exclusive Gram-Negative Spectrum Wall Inhibitors

Glycopeptides and Lipoglycopeptides Substrate-Binding Wall Inhibitors

Aminoglycosides Protein Synthesis Inhibitors - 30S

Macrolides and Ketolides Protein Synthesis Inhibitors - 50S

Lincosamides (Clindamycin) Protein Synthesis Inhibitors - 50S

Tetracyclines and Glycylcyclines Extended Spectrum Protein Synthesis Inhibitors

Oxazolidinones Protein Synthesis Inhibitors - Initiation Phase

Cyclic Lipopeptides and Polymyxins Membrane Destroyer Agents

Fluoroquinolones Inhibitors of Cellular Replication and Topology

Sulfonamides and Cotrimoxazole Synthetic Inhibitors of Metabolic Pathways

Nitroimidazoles (Metronidazole) Nucleic Acid Destroying Agents

Fosfomycin and Nitrofurans Urinary Antiseptics and Early Wall Inhibitors

Azole Antifungals Ergosterol Synthesis Inhibitors

Echinocandines and Historical Reserves Wall Synthesis Inhibitors and Polyenes

Synthesis: Integrated Antimicrobial Clinical Pathway Atlas of Pharmacoselection and Precision Decisions

Biophysical mechanisms of pharmacological reversal Pathophysiology of Toxicity

N-Acetylcysteine ​​(NAC) Metabolic and Enzymatic Reversal

Atropine Muscarinic Receptor Antagonist

Pralidoxime (2-PAM) Acetylcholinesterase Reactivator

Flumazenil GABA-A Receptor Antagonist

Naloxone Opioid Receptor Antagonist

Anti-Digoxin Antibody Fab Fragments High Specificity Immunotherapy

Fomepizole (4-Methylpyrazole) Alcohol Dehydrogenase Inhibitor

Methylene Blue Reversal of Methemoglobinemia

Protamine Sulfate Physical-Chemical Antagonist

Idarucizumab Monoclonal Reversal Antibody

Andexanet Alfa Reversal Modified Recombinant Protein

Deferoxamine Iron Chelating Agent

Dimercaprol (BAL - British Anti-Lewisite) Heavy Metal Chelating Agent

Calcium Disodium Edetate (\(CaNa_2EDTA\)) Lead Chelating Agent

Hydroxocobalamin (Vitamin B12a) Antidote for Cyanide

Physostigmine (Eserine) Reversible Acetylcholinesterase Inhibitor

Glucagon Hormone Reversal Agonist

Intravenous Lipid Emulsion (ILE - Intralipid) Lipid Emulsion Therapy

Phytonadione (Vitamin K1) Coagulation Synthesis Co-Factor

Penicillamine (D-Penicillamine) Oral Chelating Agent

Summary of interactions and risks of antidotes Toxicological Safety Matrix

Key concepts in immunopharmacology, oncology and toxicology Pharmacokinetic Fundamentals

Calcineurin inhibitors and immunophilias Immunology

Immunosuppressive antimetabolites Immunology

Monoclonal antibodies and anti-TNF therapies Immunology

Lymphocyte receptor and cytokine modulators Immunology

Alkylating agents and platinums Basic Oncology

Antimetabolites and antitumor antibiotics Basic Oncology

Inhibitors of microtubules and nuclear enzymes Basic Oncology

Targeted oncological therapies (mAB and tyrosine kinase inhibitors) Basic Oncology

Oncological hormone therapy and hormonal antagonists Basic Oncology

Specific antidotes for drug poisoning Clinical Toxicology

Chemical antidotes, environmental poisoning and chelators Clinical Toxicology

New generation specific reverters Cutting-edge toxicology

Analytical summary: systemic toxicities and their specific antidotes Immunology, Oncology and Toxicology

Principles of Transepidermal Penetration and Vehicle Selection Cutaneous Pharmacokinetic Fundamentals

Topical Retinoids: Tretinoin, Adapalene and Tazarotene Cell Differentiation Modulators

Systemic Retinoids: Isotretinoin and Acitretin Systemic Therapies in Severe Acne and Psoriasis

Topical Corticosteroids Immunosuppression and Anti-inflammatories for Local Use

Topical Calcineurin Inhibitors: Tacrolimus and Pimecrolimus Topical Immunomodulators Free of Skin Atrophy

Methotrexate Systemic Immunomodulatory Therapy in Psoriasis

Cyclosporin (Cyclosporin A) Rapid Immunosuppression in Severe Dermatoses

Anti-TNF-α Biological Therapies: Adalimumab and Infliximab Highly Selective Targeted Immunotherapy

Anti-IL-17 Biological Therapies: Secukinumab and Ixekizumab Latest Generation Immunotherapy in Severe Psoriasis

Biological Therapies Anti-IL-12/23 (Ustekinumab) and Anti-IL-23 (Guselkumab, Risankizumab) Selective Immunomodulation of the Pathogenic Axis of Psoriasis

Dupilumab Immunobiology of Atopic Dermatitis

Janus Kinase (JAK) Inhibitors: Tofacitinib, Ruxolitinib, Baricitinib and Abrocitinib Small Molecule Modulators of Intracellular Pathways

Antifungals: Terbinafine, Itraconazole and Fluconazole Therapeutics in Cutaneous Mycoses and Onychomycosis

Antimicrobials in Acne and Rosacea: Doxycycline, Minocycline and Topical Metronidazole Follicular Antimicrobial and Anti-inflammatory Therapeutics

Antiparasitics: Ivermectin (Topical and Systemic) and Permethrin Treatment of Ectoparasitosis and Skin Acarosis

Local and Systemic Oncological Therapies: Imiquimod, Topical 5-Fluorouracil and Vismodegib Oncological Dermatology and Premalignant Lesions

Local Anesthetics: Lidocaine, Prilocaine and Bupivacaine Anesthesia and Pain Control in Dermatological Procedures

Integrated Summary of Pharmacological Adjustment and Safety Comparative Table of Clinical Settings and Safety

Physiology of Ocular Barriers and Topical Pharmacokinetics Dynamic Fundamentals

Latanoprost, Travoprost, Bimatoprost Prostaglandin Analogs (FP)

Timolol, Betaxolol Beta-Adrenergic Antagonists

Brimonidine, Apraclonidine Selective Sympathomimetics

Dorzolamide, Brinzolamide, Acetazolamide Bicarbonate Transport Modulators

Netarsudil Rho-kinase inhibitors

Pilocarpine Direct Acting Cholinergic Agonists

Atropine, Cyclopentolate, Tropicamide Muscarinic Antagonists

Phenylephrine Direct Alpha-1 Adrenergic Agonists

Dexamethasone, Prednisolone, Fluorometholone, Loteprednol Ocular Immune Response Modulators

Nepafenac, Ketorolac, Bromfenac Prostanoid Synthesis Inhibitors

Olopatadine, Ketotifen, Alcaftadine Rapid-Acting Immunomodulators

Ciclosporin A, Lifitegrast Surface Immunomodulators

Tobramycin, Moxifloxacin, Erythromycin Antimicrobials of the Previous Segment

Ganciclovir, Acyclovir Chemotherapeutics Antivirals

Natamycin, Amphotericin B Ocular Antifungal Agents

Ranibizumab, Aflibercept, Faricimab, Bevacizumab Retinal Angiogenesis Modulators

Fluorescein, Rose Bengal, Indocyanine Green Colorants and Surface Indicators

Hyaluronic Acid, Carboxymethylcellulose, Trehalose Tear Film Stability Modulators

Atlas of Pharmacological Selection and Systemic Toxicity Profile Integrated Clinical Selection and Reference Guide

Introduction and Gestational Pharmacokinetic Methodology Practice Fundamentals

Oxytocin Uterotonics

Carbetocin Uterotonics

Misoprostol Prostaglandins

Dinoprostone Prostaglandins

Methylergometrine Uterotonics

Atosiban Tocolytics

Nifedipine Tocolytics

Beta-adrenergic (Ritodrine) Tocolytics

Magnesium sulfate Critical Obstetric Therapies

Indomethacin Tocolytics

Micronized Progesterone Obstetric Hormonotherapy

Combined Oral Contraceptives (COCs) Endocrine Gynecology and Contraception

Progestin-Only Contraceptives Endocrine Gynecology and Contraception

Selective Estrogen Receptor Modulators (SERMs) Oncological and Endocrine Gynecology

Aromatase Inhibitors Gynecology Oncology and Reproduction

GnRH Modulators (Agonists and Antagonists) Endocrine Gynecology and Reproduction

Ovulation Inducers (Clomiphene Citrate / Gonadotropins) Reproductive Medicine

Dopaminergic Agonists Endocrine Gynecology

Tranexamic Acid Gynecological Medical Therapies

Mifepristone and Methotrexate Gynecology Oncology and Reproduction

Anti-D immunoglobulin Obstetric Immunotherapy

Maternal-Fetal Antimicrobials Anti-infectives in Obstetrics

Gestational Antihypertensives Critical Obstetric Therapies

Gestational Diabetes Critical Obstetric Therapies

Antenatal Corticosteroids Critical Obstetric Therapies

Synthesis and Summary of High Complexity Monitoring Integration and Clinical Review

Biochemical dynamics of micronutrients Fundamentals of Cellular Nutrition

Vitamin A (Retinol, Retinyl Esters and Carotenoids) Fat-soluble Vitamins

Vitamin D3 (Cholecalciferol) and Calcitriol Fat-soluble Vitamins

Vitamin E (Tocopherols and Tocotrienols) Fat-soluble Vitamins

Vitamin K (Phytonadione and Menaquinones) Fat-soluble Vitamins

Vitamin B1 (Thiamin) Water-soluble vitamins

Vitamin B2 (Riboflavin) and Vitamin B3 (Niacin) Water-soluble vitamins

Vitamin B5 (Pantothenic Acid) and Vitamin B6 (Pyridoxine) Water-soluble vitamins

Vitamin B7 (Biotin) and Vitamin B9 (Folic Acid) Water-soluble vitamins

Vitamin B12 (Cobalamin) Water-soluble vitamins

Vitamin C (Ascorbic Acid) Water-soluble vitamins

Calcium and Phosphorus Essential Minerals

Iron (Load Physiology and Formulations) Essential Minerals

Magnesium and Zinc Essential Minerals

Trace elements: Selenium, Copper and Iodine Essential Minerals

Omega-3 Polyunsaturated Fatty Acids (EPA and DHA) Biological Modulators and Lipids

Clinical Amino Acids: N-Acetylcysteine, Glutamine and Creatine Biological Modulators and Amino Acids

Probiotics and Prebiotics Biological Modulators and Microbiota

Posological guidelines, limits and organic adjustment Dosage Analysis and Safety Profiles

Kinetic Principles of Systemic Oncological Treatment Pharmacokinetic Fundamentals and Dosage

Nitrogen Mustards and Oxazaphosphorines: Cyclophosphamide and Ifosfamide Classic Cytotoxics · DNA Modifiers

Platinum Coordinates: Cisplatin, Carboplatin and Oxaliplatin High Density Cytotoxics · Metallodrugs

Pyrimidine Analogs: 5-Fluorouracil and Capecitabine Cellular Synthetic Blockade Modulators

Folate Analogs at Oncogenic Doses: Methotrexate Competitive Inhibition of Purines and Pyrimidines

Cytidine Analogues: Cytarabine and Gemcitabine Cytotoxic DNA Incorporators · Nucleosides

Anthracyclines and Intercalation Inhibitors: Doxorubicin and Epirubicin High Potency Intercalation Cytotoxics

Topoisomerase I and II inhibitors: Irinotecan and Etoposide Inhibitors of Cell Topology and the Mitotic Cycle

Microtubule Modulators (Taxanes): Paclitaxel and Docetaxel Mitosis and Cytoskeleton Inhibitors

Vinca Alkaloids: Vincristine and Vinblastine Inhibitors of Mitotic and Neuronal Assembly

Targeted Monoclonal Antibodies: Anti-HER2 (Trastuzumab and Pertuzumab) Targeted Immunotherapy and Epidermal Growth Inhibitors

Monoclonal Antibodies: Cetuximab (Anti-EGFR) and Bevacizumab (Anti-VEGF) Vascular Signaling and Growth Blockade Immunology

Selective Tyrosine Kinase Inhibitors: Imatinib and Osimertinib Targeted Small Molecule Therapies

Multikinase Inhibitors: Sorafenib and Regorafenib Targeted Multikinase and Antiangiogenic Therapies

Immune Checkpoint Inhibitors (Checkpoints): Pembrolizumab, Nivolumab and Ipilimumab Advanced Biological Immunomodulation and T Cell Activation

Oncological Endocrine Therapy: Tamoxifen, Anastrozole and Letrozole Endocrine Therapeutics of Nuclear Receptor Blockade

CDK4/6 and PARP inhibitors: Palbociclib and Olaparib Therapies Directed at the Cell Cycle and DNA Repair

Advanced Clinical Support: Febrile Neutropenia and Tumor Lysis Syndrome Treatment of Oncological Complications and Emergencies

Integrated Summary of Pharmacological Adjustment and Safety Comparative Table of Clinical Settings and Safety

Barrier Principles, Membrane Permeability and Topical Deposition Pharmacoclinical Fundamentals in ENT

Ciprofloxacin / Dexamethasone (Otic) Topical Otological Therapeutics

Betahistine dihydrochloride Otoneurology and Cochlear Microcirculation

Methylprednisolone / Intratympanic Dexamethasone Emergency Otoneurology and Local Therapy

Intratympanic Gentamicin Advanced Otoneurology and Ablative Therapy

Fluticasone Propionate / Mometasone Furoate (Intranasal) Rhinosinusology and Allergy

Bilastine / Rupatadine Allergology and Second Generation Antihistamines

Oxymetazoline Hydrochloride (Intranasal) Rhinosinusology and Mucosal Adrenergic Physiology

Montelukast Sodium Rhinosinusology and Antileukotrienes

Nystatin / Fluconazole Oral Cavity and Pharynx

Pilocarpine Hydrochloride Oral Cavity and Glandular Stimulation

Benzydamine / Chlorhexidine (Mouthwashes and Sprays) Oral Cavity and Pharynx

Amoxicillin/Clavulanic Acid Upper Airway and Neck Infections

Ceftriaxone / Clindamycin (Systemic Use) Deep Neck Space and Surgical Infections

Methylprednisolone / Deflazacort Systemic Corticotherapy in ENT

Adrenaline (Epinephrine) Nebulized ENT Emergencies and Airway Support

Tranexamic Acid Hemostasis and Vascular Therapeutics in ENT

Topical Hemostatic Biomaterials Surgical Procedures and Biomaterials in ENT

Integrated Summary of Adjustment, Pharmacokinetics and Safety Comparative Table of Clinical Settings